Azeloprazole

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameAzeloprazole
Drug Alias Name西唑来汀CizolirtinumCizolirtinaCizolirtineZ-215 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProton pump inhibitors
TargetsProton pump
Therapy Area/IndicationsEsophagitis, PepticGastroesophageal Reflux
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomJapan
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEisai Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZeria PharmaceuticalEisai Co Ltd
Active IndicationsN/A
Inactive IndicationsEsophagitis, PepticGastroesophageal Reflux

Other Information

ATC CodeN/A
Related LinksN/A